Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: Osteopontin localization

Kidney International

Volumn 68, Issue 1, 2005, Pages 145-154

  Evan, Andrew P ^a   Coe, Fredric L ^b   Rittling, Susan R ^b   Bledsoe, Sharon M ^b   Shao, Youzhi ^b   Lingeman, James E ^b   Worcester, Elaine M ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Immunohistochemistry; Loops of Henle; Randall's plague; Ultrastructure

Indexed keywords

APATITE; CALCIUM OXALATE; OSTEOPONTIN; PROTEIN ANTIBODY; SIALOGLYCOPROTEIN; SPP1 PROTEIN, HUMAN;

ARTICLE; BASEMENT MEMBRANE; CALCIUM OXALATE STONE; CLINICAL ARTICLE; HENLE LOOP; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOELECTRON MICROSCOPY; IMMUNOGOLD LABELING; IMMUNOHISTOCHEMISTRY; KIDNEY COLLECTING TUBULE; KIDNEY INTERSTITIUM; KIDNEY MEDULLA; MICROSCOPY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN URINE LEVEL; STONE FORMATION; SYNCYTIUM; TRANSMISSION ELECTRON MICROSCOPY; METABOLISM; NEPHROLITHIASIS; PATHOLOGY; ULTRASTRUCTURE;

APATITES; BASEMENT MEMBRANE; CALCIUM OXALATE; HUMANS; KIDNEY CALCULI; KIDNEY MEDULLA; LOOP OF HENLE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, IMMUNOELECTRON; OSTEOPONTIN; SIALOGLYCOPROTEINS;

EID: 24944466594     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00388.x     Document Type: Article

References (24)

1. EVAN AP, LINGEMAN J, PARKS JH, et al: Randall plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607-616, 2003
2. KUO, J, EVAN AP, et al: Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int 64:2150-2154, 2003
3. PAK CYC, HAYASHI Y, FINLAYSON B, CHU S: Estimation of the state of supersaturation of brushite and calcium oxalate in urine: A comparison of three methods. J Lab Clin Med 89:891-909, 1977
4. Low RK, STOLLER ML: Endoscopic mapping of renal papillae for Randall's plaques in patients with urinary stone disease. J Urol 158:2062-2064, 1997
5. HOYER JR, OTVOS L, JR., URGE L: Osteopontin in urinary stone formation. Ann NY Acad Sci 760:257-265, 1995
6. BUCHHOLZ NP, KIM D-S, GROVER PK, et al: The effect of warfarin therapy on the charge properties of urinary prothrombin fragment 1 and crystallization of calcium oxalate in undiluted human urine. J Bone Mineral Res 14:1003-1012, 1999
7. IIDA S, PECK AB, JOHNSON-TARDIEU J, et al: Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis. J Am Soc Nephrol 10:986-996, 1999
8. PILLAY S, ASPLIN JR, COE FL: Evidence that calgranulin is produced by kidney cells and is an inhibitor of calicum oxalate crystallization. Am J Physiol 275:F255-F261, 1998
9. HESS B, NAKAGAWA Y, PARKS JH, COE FL: Molecular abnormality of Tamm Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol 29:F569-F578, 1991
10. EVAN AP, BLEDSOE SB, SMITH SB, BUSHINSKY DA: Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats. Kidney Int 65:154-161, 2004
11. KHAN SR, HACKETT RL: Crystal-matrix relationships in experimentally induced urinary calcium oxalate monohydrate crystals, an ultrastructural study. Calcif Tissue Int 41:157-163, 1987
12. KHAN SR, KOK DJ: Modulators of urinary stone rormation. Frontiers in Bioscience 9:1450-1482, 2004
13. HUDKINS KL, GIACHELLI CM, CUI Y, et al: Osteopontin expression in fetal and mature human kidney. J Am Soc Nephrol 10:444-457, 1999
14. XIE Y, SAKATSUME M, NISHI S, et al: Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 60:1645-1657, 2001
15. DENHARDT DT, GIACHELLI CM, RITTLING SR: Role of osteopontin in cellular signalling and toxicant injury. Ann Rev Pharmacol Toxicol 41:723-749, 2001
16. BUTLER WT, RIDDALL AL, MCKEE MD: Osteopontin, in Principles of Bone Biology, edited by Bilezikian JP, Raisz LG, Rodan GA, San Diego, Academic Press, 1996, pp 167-181
17. MOE SM, O'NEILL KD, DUAN D, et al: Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61:638-647, 2002
18. BESHENSKY AM, WESSON JA, WORCESTER EM, et al: Effects of urinary macromolecules on hydroxyapatite crystal formation. J Am Soc Nephrol 12:2108-2116, 2001
19. ASPLIN JR, ASSENAULT D, PARKS JH, et al: Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int 53:194-199, 1998
20. WESSON JA, JOHNSON RJ, MAZALLI M, et al: Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 14:139-147, 2003
21. CHAU H, EL-MAADAWY S, MCKEE MD, TENENHOUSE HS: Renal calcification in Mice homozygous for the disrupted type 2a Na/Pi co-transporter gene Npt2. J Bone Miner Res 18:644-657, 2003
22. PAMMENA DA, ROBERTSON KA, LITVINOVA O, et al: Inhibition of hydroxyapatite formation by osteopontin phosphate peptides. Biochem J 378:1083-1087, 2004
23. WADA T, MCKEE MD, STEITZ S, GIACHELLI CM: Calcification of vascular smooth muscle cell cultures: Inhibition by osteopontin. Circ Res 84:166-178, 1999
24. ITO S, SAITO T, AMANO K: In vitro apatite induction by osteopontin: Interfacial energy for hydroxyapatite nucleation on osteopontin. J Biomed Mater Res 69a:11-16, 2004